Federal Circuit Rules For Competitive Technologies In Patent Suit Vs. LabCorp

Law360, New York (June 8, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s decision that Laboratory Corporation of America Holdings willfully contributed to and induced infringement of Competitive Technologies’s patent for a technology used in diagnoses of heart conditions.

In November 2002, Senior Judge Zita L. Weinshienk of the U.S. District Court for the District of Colorado ruled that LabCorp willfully contributed to and induced infringement of CTT's so-called homocysteine assay patent.

CTT, along with Metabolite Laboratories, sued LabCorp in May 1999. The complaint alleged,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.